DrugPatentWatch Database Preview

TENORMIN Drug Profile

« Back to Dashboard

When do Tenormin patents expire, and when can generic versions of Tenormin launch?

Tenormin is a drug marketed by Astrazeneca and Alvogen Malta and is included in two NDAs.

The generic ingredient in TENORMIN is atenolol. There are thirty-three drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the atenolol profile page.

Summary for TENORMIN

US Patents:	0
Applicants:	2
NDAs:	2
Suppliers / Packagers:	2
Bulk Api Vendors:	103
Clinical Trials:	5
Patent Applications:	4,383
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	TENORMIN at DailyMed

Pharmacology for TENORMIN

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for TENORMIN

Adrenergic beta-1 Receptor Antagonists

Anti-Arrhythmia Agents

Antihypertensive Agents

Sympatholytics

Synonyms for TENORMIN

( inverted question mark)-Atenolol

(?)-Atenolol

(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide

(+-)-Atenolol

(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide

(+/-)-4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide

(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide

(+/-)-Atenolol

(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide

(A+/-)-Atenolol

(inverted question mark)-Atenolol

(r,s)-atenolol

(RS)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide

(RS)-Atenolol

(y)-Atenolol

1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol

106020-65-9

122A687

2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide

2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid

2-(4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl)acetamide

2-(4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenyl)acetamide

2-(4-{2-hydroxy-3-[(methylethyl)amino]propoxy}phenyl)acetamide

2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide

2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide

2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide

2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide

2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide

2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide

2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]-phenyl}acetamide

2-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide

2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide

29122-68-7

3B1-006626

4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide

4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide

4-[2-Hydroxy-3-(isopropylamino)-propoxy]phenylacetamide

4-[2'-Hydroxy-3'-(isopropylamino)-propoxy]phenylacetamide

4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide

60966-51-0

A 7655

AB00052208_16

AB00052208-13

AB00052208-15

AB0011597

AC-8245

AC1L1D99

AC1Q1QBX

Acetamide, 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-

Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)

Aircrit

AK-88721

AKOS005111050

Alinor

Altol

AN-7253

Anselol

Antipressan

ANW-45215

API0001553

Apo-Atenolol

ARONIS23884

Artrenolol

Atcard

Atcardil

Atecard

Atehexal

Atenblock

Atendol

Atenet

Ateni

Atenil

Atenol

Atenol 1A pharma

Atenol acis

Atenol AL

Atenol Atid

Atenol Cophar

Atenol ct

Atenol Fecofar

Atenol Gador

Atenol Genericon

Atenol GNR

Atenol Heumann

Atenol MSD

Atenol NM Pharma

Atenol Nordic

Atenol PB

Atenol Quesada

Atenol Stada

Atenol Tika

Atenol Trom

Atenol von ct

Atenol-Mepha

Atenol-ratiopharm

Atenol-Wolff

Atenolin

atenolol

Atenolol (JAN/USP)

Atenolol (JP15/USP/INN)

Atenolol (JP17/USP/INN)

Atenolol [USAN:BAN:INN:JAN]

Atenolol [USAN:INN:BAN:JAN]

Atenolol [USAN:USP:INN:BAN:JAN]

Atenolol 1.0 mg/ml in Acetonitrile

Atenolol Bp

Atenolol, >=98% (TLC), powder

Atenolol, analytical reference material

Atenolol, European Pharmacopoeia (EP) Reference Standard

Atenolol, Pharmaceutical Secondary Standard; Certified Reference Material

Atenolol, United States Pharmacopeia (USP) Reference Standard

Atenololum

Atenololum [INN-Latin]

Atenomel

Atereal

Aterol

AX8005715

BB_SC-01519

BB_SC-1519

BBC/163

BBL009276

BC201805

BDBM25753

Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-

BENZENEACETAMIDE, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-, (+-)-

Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-

benzeneacetamide, 4-[2'-hydroxy-3;-[(1-methylethyl)amino]propoxy]-

Betablok

Betacard

Betasyn

Betatop Ge

BG0049

BIM-0050109.0001

Blocotenol

Blokium

BRD-A20239487-001-02-5

BRN 2739235

BSPBio_002915

CA0145

Cardaxen

Cardiopress

CAS-29122-68-7

CCG-39010

CCRIS 4196

CHEBI:2904

CHEMBL24

Corotenol

CPD000036768

CS-2927

CTK3J2163

Cuxanorm

D00235

D01UXC

DB00335

DivK1c_000057

dl-Atenolol

DR000815

DSSTox_CID_2628

DSSTox_GSID_22628

DSSTox_RID_76663

DTXSID2022628

Duraatenolol

duratenol

EINECS 249-451-7

EINECS 262-544-7

EN300-119532

EU-0100121

Evitocor

Farnormin

Felo-Bits

FT-0622499

FT-0693045

GEO-03413

GTPL548

Hipres

HMS1569L13

HMS1921H09

HMS2090I19

HMS2092D19

HMS2233E06

HMS3259K08

HMS3260I04

HMS3266K13

HMS3369B14

HMS3369D20

HMS3369P20

HMS500C19

HSDB 6526

HY-17498

Hypoten

I01-3572

Ibinolo

ICI 66,082

ICI 66082

ICI-66082

IDI1_000057

InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)

Internolol

J10009

Jenatenol

Juvental

KB-222053

KB-47450

KB-62479

KBio1_000057

KBio2_001844

KBio2_004412

KBio2_006980

KBio3_002415

KBioGR_000790

KBioSS_001844

KS-00000XIG

KS-000046IQ

KS-5341

KSC492C6H

L000116

Lo-ten

Lopac0_000121

Loten

Lotenal

LP00121

LS-28557

LS-9707

MCULE-9148694071

METKIMKYRPQLGS-UHFFFAOYSA-

METKIMKYRPQLGS-UHFFFAOYSA-N

MFCD00057645

MLS000069622

MLS001066372

MLS001074163

MLS001304038

MolPort-001-792-717

MRF-0000571

Myocord

NC00548

NCGC00015007-06

NCGC00015007-07

NCGC00015007-08

NCGC00015007-09

NCGC00015007-10

NCGC00015007-11

NCGC00015007-13

NCGC00024566-03

NCGC00024566-04

NCGC00024566-05

NCGC00024566-06

NCGC00024566-07

NCGC00255122-01

NCGC00260806-01

Neatenol

NINDS_000057

Normalol

Normiten

Noten

NSC-757832

NSC757832

Opera_ID_1283

Oprea1_448775

OR108794

OR294583

Oraday

Ormidol

Panapres

Pharmakon1600-01501127

Plenacor

Premorine

Prenolol

Prenormine

Prinorm

Q-200656

RTR-012731

SAM002564193

SBB056998

SBI-0050109.P003

SC-19545

Scheinpharm Atenol

SCHEMBL4362

Seles beta

Selobloc

Serten

Servitenol

SMR000036768

SPBio_001482

Spectrum_001364

SPECTRUM1501127

Spectrum2_001411

Spectrum3_001448

Spectrum4_000435

Spectrum5_001509

SR-01000000159

SR-01000000159-2

ST024754

ST2403914

Stermin

STK528649

Tenidon

Teno-basan

Tenobloc

Tenoblock

Tenolol

Tenoprin

Tenoretic (Salt/Mix)

Tenormin (TN)

Tenormine

Tenormine [French]

Tensimin

Tensotin

Tox21_302426

Tox21_500121

TR-012731

Tredol

Unibloc

Uniloc

Vascoten

Vericordin

Wesipin

Xaten

Z-0828

Z1541638518

ZX-AS004380

US Patents and Regulatory Information for TENORMIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca	TENORMIN	atenolol	INJECTABLE;INJECTION	019058-001	Sep 13, 1989		DISCN	Yes	No
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-004	Apr 9, 1990	AB	RX	Yes	No
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No

Expired US Patents for TENORMIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-002	Approved Prior to Jan 1, 1982
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-001	Approved Prior to Jan 1, 1982
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-001	Approved Prior to Jan 1, 1982
Alvogen Malta	TENORMIN	atenolol	TABLET;ORAL	018240-004	Apr 9, 1990